Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Summary Androgen receptor (AR) signaling is a distinctive feature of prostate carcinoma (PC) and represents the major therapeutic target for treating metastatic prostate cancer (mPC).